Browsing: amid

Neutrogena’s silence is drawing more scrutiny. Shares of parent company Kenvue Inc. have fallen as the skincare brand faces mounting backlash over Hayden Panettiere’s claim that it dropped her for speaking publicly about postpartum depression. Kenvue stock recently traded near $19.14 as calls to boycott Neutrogena spread following Panettiere’s death at 36 on Aug. 16.